VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+3.98%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$77.4B
AUM Growth
-$741M
(-0.95%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,421
New
35
Increased
882
Reduced
429
Closed
29
Top Buys
| 1 |
Philip Morris
PM
|
$389M |
| 2 |
RTX Corp
RTX
|
$337M |
| 3 |
Cadence Design Systems
CDNS
|
$207M |
| 4 |
Synopsys
SNPS
|
$201M |
| 5 |
Manhattan Associates
MANH
|
$184M |
Top Sells
| 1 |
TSMC
TSM
|
$327M |
| 2 |
Gilead Sciences
GILD
|
$306M |
| 3 |
Newmont
NEM
|
$287M |
| 4 |
Broadcom
AVGO
|
$253M |
| 5 |
Agnico Eagle Mines
AEM
|
$249M |
Sector Composition
| 1 | Technology | 36.96% |
| 2 | Materials | 26.3% |
| 3 | Healthcare | 8.41% |
| 4 | Industrials | 7.28% |
| 5 | Financials | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Haleon
HLN
$43.9B
| $37.2M | 0.05% |
3,612,443
+103,043
| +3% | +$1.06M |
|
227
Tidewater
TDW
$2.86B
| $37.1M | 0.05% |
878,049
+41,796
| +5% | +$1.77M |
|
228
Strategy Inc Common Stock Class A
MSTR
$95.2B
| $37M | 0.05% |
128,448
+9,318
| +8% | +$2.69M |
|
229
Sanofi
SNY
$113B
| $36.7M | 0.05% |
662,091
-671
| -0.1% | -$37.2K |
|
230
Sociedad Química y Minera de Chile
SQM
$13.1B
| $36.6M | 0.05% |
919,960
+115,047
| +14% | +$4.57M |
|
231
Teck Resources
TECK
$16.8B
| $36.3M | 0.05% |
995,227
-171,191
| -15% | -$6.24M |
|
232
Novartis
NVS
$251B
| $36.1M | 0.05% |
323,379
-4,235
| -1% | -$472K |
|
233
Teva Pharmaceuticals
TEVA
$21.7B
| $35.7M | 0.05% |
2,320,892
+705,197
| +44% | +$10.8M |
|
234
Prospect Capital
PSEC
$1.34B
| $35.5M | 0.05% |
8,655,753
+528,136
| +6% | +$2.17M |
|
235
Regeneron Pharmaceuticals
REGN
$60.8B
| $35M | 0.05% |
55,227
-3,306
| -6% | -$2.1M |
|
236
Intuitive Surgical
ISRG
$167B
| $35M | 0.05% |
70,670
+1,135
| +2% | +$562K |
|
237
Centrus Energy
LEU
$3.74B
| $34.9M | 0.05% |
560,984
+236,430
| +73% | +$14.7M |
|
|
SA
238
Seabridge Gold
SA
$1.81B
| $34.7M | 0.04% |
2,972,604
-481,367
| -14% | -$5.62M |
|
239
Valaris
VAL
$3.64B
| $34.4M | 0.04% |
876,873
-50,747
| -5% | -$1.99M |
|
240
Palo Alto Networks
PANW
$130B
| $34.2M | 0.04% |
200,284
+676
| +0.3% | +$115K |
|
241
Weyerhaeuser
WY
$18.9B
| $33.4M | 0.04% |
1,139,010
-23,996
| -2% | -$703K |
|
242
Southern Company
SO
$101B
| $33.3M | 0.04% |
362,625
+15,574
| +4% | +$1.43M |
|
243
Enbridge
ENB
$105B
| $33.2M | 0.04% |
749,295
+32,823
| +5% | +$1.45M |
|
244
Vanguard Total Bond Market
BND
$135B
| $32.9M | 0.04% |
448,289
+295,538
| +193% | +$21.7M |
|
245
AGNC Investment
AGNC
$10.8B
| $32.7M | 0.04% |
3,417,568
+447,784
| +15% | +$4.29M |
|
246
AstraZeneca
AZN
$253B
| $32.6M | 0.04% |
442,935
-16,625
| -4% | -$1.22M |
|
247
Oceaneering
OII
$2.41B
| $32.4M | 0.04% |
1,483,304
-85,177
| -5% | -$1.86M |
|
248
Takeda Pharmaceutical
TAK
$48.6B
| $32.3M | 0.04% |
2,172,384
-38,044
| -2% | -$566K |
|
249
GSK
GSK
$81.5B
| $31.4M | 0.04% |
809,665
-34,374
| -4% | -$1.33M |
|
250
Duke Energy
DUK
$93.8B
| $31.1M | 0.04% |
255,090
+14,996
| +6% | +$1.83M |
|